Investment Thesis
With over $100 billion in market cap and 400,000 plus customers in the pharmaceutical and biotech sector, Thermo Fisher (TMO) is a leader in the field. The firm has produced stellar results year over year, both yearly revenue growth and profit margin averaged roughly 10.75% since 2011. With approximately 39% of total capital financed by long-term debt, the firm has a strong capital structure. The firm's largest revenue segment is Laboratory products and services, followed by Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. For the full year of 2019, the